The copyright outcomes of 4-AcO-copyright are believed to originate from its activity to be a partial agonist with the 5-HT2A receptor. Nonetheless, the purpose of those interactions and how they cause the copyright expertise is the subject of ongoing scientific investigation.copyright therapy, also often called copyright-assisted therapy,